Certified by Founder Lodge
Verge Genomics
United States - South San Francisco, CA
INVESTOR
START UP
1 Disclosed Funding Rounds $98,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases. Our platform uses pati
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 16 ,2021 | Series B | $98,000,000 |
Ochre Bio
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Avallon AI (YC X25) | $4,600,000 | (Nov 7, 2025)
Kaizen Labs | $12,000,000 | (Nov 7, 2025)
SiteLabs | $2,000,000 | (Nov 7, 2025)
Fintary | $10,000,000 | (Nov 7, 2025)
Inception | $50,000,000 | (Nov 7, 2025)
